Hattori Takashi, Khan Mohammad M H, Colman Robert W, Edmunds L Henry
Harrison Department of Surgical Research, School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
J Am Coll Cardiol. 2005 Aug 16;46(4):707-13. doi: 10.1016/j.jacc.2005.05.040.
The purpose of this study was to test the hypothesis that activated monocytes with soluble plasma tissue factor (pTF) activate factors VII and X to generate thrombin.
Despite heparin, thrombin is progressively generated during cardiac surgery with cardiopulmonary bypass (CPB), produces intravascular fibrin and fibrinolysis, and causes serious thromboembolic and nonsurgical bleeding complications. Thrombin is primarily produced in the surgical wound, but mechanisms are unclear.
In 13 patients, interactions of mononuclear cells, platelets, pTF, and pTF fractions to activate factors VII and X were evaluated in pre-bypass, perfusate, and pericardial wound blood before and during CPB.
Monocytes are activated in wound, but not in pre-bypass or perfusate plasma (monocyte chemotactic protein-1 = 29.5 +/- 2.1 pmoles/l vs. 2.8 +/- 1.2 pmoles/l and 3.3 +/-1.4 pmoles/l, respectively). Wound pTF is substantially elevated compared to other locations (3.64 +/- 0.45 pmoles/l vs. 0.71 +/- 0.65 pmoles/l and 1.31 +/- 1.4 pmoles/l). Supernatant wound pTF contains 81.7% of TF antigen; wound microparticle pTF contains 18.3%. Wound monocytes and all C5a-stimulated monocytes (but not activated platelets) completely convert factor VII to factor VIIa with wound pTF. Activated monocytes more efficiently activate factor X with wound supernatant TF/factor VII(VIIa) complex than with wound microparticle TF/factor VII(fVIIa). The correlation coefficient (r) between wound thrombin generation (F1.2) and wound pTF concentration is 0.944 (p = 0.0004).
During cardiac surgery with CPB, wound monocytes plus wound pTF or wound microparticle-free supernatant pTF preferentially accelerate activation of factor VII and factor X. This system represents a novel mechanism for thrombin generation via the TF coagulation pathway.
本研究旨在验证以下假设,即具有可溶性血浆组织因子(pTF)的活化单核细胞激活因子VII和X以生成凝血酶。
尽管使用了肝素,但在体外循环(CPB)心脏手术期间仍会逐渐生成凝血酶,产生血管内纤维蛋白和纤维蛋白溶解,并导致严重的血栓栓塞和非手术出血并发症。凝血酶主要在手术伤口处产生,但其机制尚不清楚。
在13名患者中,评估了体外循环前、灌注液以及CPB期间心包伤口血液中单核细胞、血小板、pTF和pTF组分激活因子VII和X的相互作用。
单核细胞在伤口处被激活,但在体外循环前或灌注液血浆中未被激活(单核细胞趋化蛋白-1分别为29.5±2.1皮摩尔/升、2.8±1.2皮摩尔/升和3.3±1.4皮摩尔/升)。与其他部位相比,伤口处的pTF显著升高(3.64±0.45皮摩尔/升、0.71±0.65皮摩尔/升和1.31±1.4皮摩尔/升)。伤口上清液中的pTF占TF抗原的81.7%;伤口微粒中的pTF占18.3%。伤口处的单核细胞以及所有经C5a刺激的单核细胞(但不包括活化血小板)可通过伤口处的pTF将因子VII完全转化为因子VIIa。与伤口微粒TF/因子VII(fVIIa)复合物相比,活化单核细胞利用伤口上清液TF/因子VII(VIIa)复合物能更有效地激活因子X。伤口凝血酶生成(F1.2)与伤口pTF浓度之间的相关系数(r)为0.944(p = 0.0004)。
在CPB心脏手术期间,伤口处的单核细胞加上伤口处的pTF或无伤口微粒的上清液pTF优先加速因子VII和因子X的激活。该系统代表了一种通过TF凝血途径生成凝血酶的新机制。